Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name (Descending) Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
49884-0324-52 49884-0324 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Sept. 15, 2011 No Longer Used
49884-0324-62 49884-0324 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Nov. 30, 2012 No Longer Used
49884-0325-11 49884-0325 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Nov. 11, 2011 No Longer Used
49884-0325-52 49884-0325 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 Nov. 11, 2011 No Longer Used
49884-0325-62 49884-0325 Ondansetron Zuplenz Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral July 5, 2010 July 31, 2012 No Longer Used
00078-0387-25 00078-0387 Zoledronic Acid Zometa 4.0 mg/5mL Ancillary Therapy Bisphosphonate Intravenous Aug. 20, 2001 Nov. 30, 2020 No Longer Used
00078-0590-61 00078-0590 Zoledronic Acid Zometa 4.0 mg/100mL Ancillary Therapy Bisphosphonate Intravenous Aug. 20, 2001 Jan. 31, 2020 No Longer Used
00006-0568-40 00006-0568 Vorinostat Zolinza 100.0 mg/1 Chemotherapy Enzyme Inhibitor HDAC Oral Oct. 6, 2006 In Use
50742-0416-05 50742-0416 zoledronic acid Zoledronic acid 4.0 mg/5mL Ancillary Therapy Bisphosphonate Intravenous Feb. 19, 2020 In Use
67457-0920-05 67457-0920 Zoledronic acid Zoledronic acid 4.0 mg/5mL Ancillary Therapy Bisphosphonate Intravenous Oct. 12, 2020 May 31, 2021 In Use

Found 10,000 results in 3 milliseconds — Export these results